Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,521.10
+105.30 (7.44%)
At close: Mar 9, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 288.38 billion as of March 9, 2026. Its market cap has increased by 53.05% in one year.
Market Cap
288.38B
Enterprise Value
301.27B
Revenue
88.50B
Ranking
n/a
PE Ratio
33.14
Stock Price
1,521.10
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 288.38B, an increase of 12.23%. That is a compound annual growth rate of 7.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 288.38B | 11.49% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 274.98B |
| Wockhardt | 211.17B |
| Piramal Pharma | 201.66B |
| Ajanta Pharma | 373.66B |
| Ipca Laboratories | 379.08B |
| Eris Lifesciences | 188.49B |
| NATCO Pharma | 182.64B |
| Alembic Pharmaceuticals | 139.26B |